HER2 positive endometrial cancer

2 total trials 2 recruiting MedDRA PT

Filter these 2 trials by phase, country, sponsor and more.

Open in Search →

Trial of T-DXd Versus SoC Chemotherapy as Adjuvant Treatment in Endometrial Cancer Recruiting

2024-519444-33-00 5 2026-03-12 "HER2-expressing endometrial cancer (IHC 3+/2+)"
Clinical trial evaluating the activity of zanidatamab for the treatment of patients with solid tumors with an alteration of the HER2 gene Recruiting

2025-522169-31-00 4 2025-10-30 "Adult Patients with HER2-IHC3+ selected solid cancers (endom"

Showing 1–2 of 2 trials